Síguenos en Twitter     Síguenos en Facebook     Síguenos en YouTube     Siguenos en Linkedin     Correo Grupsagessa     Gmail     Dropbox     Instagram     Google Drive     StumbleUpon     StumbleUpon     StumbleUpon     StumbleUpon     StumbleUpon     StumbleUpon     StumbleUpon

SOBRE EL AUTOR **

Mi foto
FACP. Colegio de médicos de Tarragona Nº 4305520 / fgcapriles@gmail.com

WORLD EMERGENCY MEDICINE SOCIETIES & RELATED

Search

Content:

miércoles, 24 de junio de 2020

Dexamethasone & COVID

PulmCrit (EMCrit)
PulmCrit – June 23, 2020 - By Josh Farkas
"Summary: The Bullet
  • Dexamethasone is now the standard of care for COVID-19 patients with acute hypoxemic respiratory failure (i.e., requiring oxygen or mechanical ventilation).
  • Available evidence does not support the use of dexamethasone in COVID-19 patients who are not requiring oxygen. Using dexamethasone too early is potentially harmful.
  • Optimal management of patients with COVID-19 might involve close monitoring of oxygenation (e.g., with home pulse oximetry). Dexamethasone should be initiated if patients become hypoxemic and require supplemental oxygen.
  • When dexamethasone supplies are exhausted, equivalent doses of other steroid may be used (e.g., methylprednisolone)."